AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $1.55M in total
- 4
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +12 vs. previous quarter
- 150
- 13F valueReported value at the end of Q2 2026
- $908.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ABCL, Q2 2026
No superinvestor reported holding ABCL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by AbCellera Biologics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 (view filing)5:21 PM ET | Aug 24 | Same day | Hayden Michael RDirector | PPurchase | +53.6K | $10.64 | +$570.4K | +4.1%1.37M after | |
| Aug 18, 2026 (view filing)2:45 PM ET | Aug 18 | Same day | Montalbano John S.Director | PPurchase | +10.0K | $11.03 | +$110.3K | +4.1%251.0K after | |
| Aug 14, 2026 (view filing)12:04 PM ET | Aug 14 | Same day | Booth AndrewChief Financial Officer | PPurchase | +37.2K | $10.32 | +$383.9K | +8.3%482.8K after | |
| Aug 14, 2026 (view filing)11:50 AM ET | Aug 12 | 2 days | Hayden Michael RDirector | PPurchase | +46.4K | $10.37 | +$481.0K | +3.6%1.32M after | |
| May 18, 2026 (view filing) | May 14 | 4 days | Montalbano John S.Director | PPurchase | +20.0K | $4.77 | +$95.4K | +9.0%241.0K after | |
| Mar 2, 2026 (view filing) | Feb 27 | 3 days | Thermopylae Holdings Ltd.10% Owner | PPurchase | +38.0K | $3.44 | +$130.7K | +0.1%56.1M after | |
| Feb 27, 2026 (view filing) | Feb 26 | 1 day | Thermopylae Holdings Ltd.10% Owner | PPurchase | +177.5K | $3.27 | +$580.3K | +0.3%56.1M after | |
| Feb 27, 2026 (view filing) | Feb 27 | Same day | Booth AndrewChief Financial Officer | PPurchase | +42.6K | $3.42 | +$145.7K | +27.8%195.6K after | |
| Nov 26, 2025 (view filing) | Nov 26 | Same day | Montalbano John S.Director | PPurchase | +50.0K | $3.57 | +$178.5K | +29.2%221.0K after | |
| Mar 11, 2025 (view filing) | Mar 11 | Same day | Thermopylae Holdings Ltd.10% Owner | PPurchase | +343.6K | $2.16 | +$742.2K | +0.6%56.1M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in AbCellera Biologics Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 33,012,138 | $259.1M | 1.30% | +2,736,200+9.0% | Added |
| Capital World Investors | 13,588,349 | $106.7M | 0.01% | +227,253+1.7% | Added |
| Two Sigma Investments, LP | 10,437,431 | $81.9M | 0.06% | −124,634−1.2% | Reduced |
| TD Waterhouse Canada Inc. | 9,568,149 | $72.6M | 0.19% | +3,4900.0% | Added |
| Bank of America Corp | 6,141,539 | $48.2M | 0.00% | +3,141,603+104.7% | Added |
| UBS Asset Management Americas Inc | 4,317,206 | $33.9M | 0.01% | −3,258,270−43.0% | Reduced |
| ArrowMark Colorado Holdings LLC | 4,105,095 | $32.2M | 1.34% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,805,309 | $29.9M | 0.00% | −234,927−5.8% | Reduced |
| Driehaus Capital Management LLC | 2,864,729 | $22.5M | 0.13% | −1,160,050−28.8% | Reduced |
| Tudor Investment Corp Et Al | 2,063,191 | $16.2M | 0.07% | −210,298−9.3% | Reduced |